Glucose metabolism in burn patients

The role of insulin and other endocrine hormones

Nikiforos Ballian, Atoosa Rabiee, Dana Andersen, Dariush Elahi, B. Robert Gibson

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Severe burn causes a catabolic response with profound effects on glucose and muscle protein metabolism. This response is characterized by hyperglycemia and loss of muscle mass, both of which have been associated with significantly increased morbidity and mortality. In critically ill surgical patients, obtaining tight glycemic control with intensive insulin therapy was shown to reduce morbidity and mortality and has increasingly become the standard of care. In addition to its well-known anti-hyperglycemic action and reduction in infections, insulin promotes muscle anabolism and regulates the systemic inflammatory response. Despite a demonstrated benefit of insulin administration on the maintenance of skeletal muscle mass, it is unknown if this effect translates to improved clinical outcomes in the thermally injured. Further, insulin therapy has the potential to cause hypoglycemia and requires frequent monitoring of blood glucose levels. A better understanding of the clinical benefit associated with tight glycemic control in the burned patient, as well as newer strategies to achieve and maintain that control, may provide improved methods to reduce the clinical morbidity and mortality in the thermally injured patient.

Original languageEnglish (US)
Pages (from-to)599-605
Number of pages7
JournalBurns
Volume36
Issue number5
DOIs
StatePublished - Aug 2010
Externally publishedYes

Fingerprint

Hormones
Insulin
Glucose
Morbidity
Mortality
Muscles
Muscle Proteins
Standard of Care
Hypoglycemia
Critical Illness
Hyperglycemia
Blood Glucose
Skeletal Muscle
Maintenance
Therapeutics
Infection

Keywords

  • Burn ICU
  • GLP-1
  • Glycemic control
  • Insulin

ASJC Scopus subject areas

  • Emergency Medicine
  • Critical Care and Intensive Care Medicine
  • Surgery

Cite this

Glucose metabolism in burn patients : The role of insulin and other endocrine hormones. / Ballian, Nikiforos; Rabiee, Atoosa; Andersen, Dana; Elahi, Dariush; Gibson, B. Robert.

In: Burns, Vol. 36, No. 5, 08.2010, p. 599-605.

Research output: Contribution to journalArticle

Ballian, Nikiforos ; Rabiee, Atoosa ; Andersen, Dana ; Elahi, Dariush ; Gibson, B. Robert. / Glucose metabolism in burn patients : The role of insulin and other endocrine hormones. In: Burns. 2010 ; Vol. 36, No. 5. pp. 599-605.
@article{325138fb63274ef0a640de99e155d21a,
title = "Glucose metabolism in burn patients: The role of insulin and other endocrine hormones",
abstract = "Severe burn causes a catabolic response with profound effects on glucose and muscle protein metabolism. This response is characterized by hyperglycemia and loss of muscle mass, both of which have been associated with significantly increased morbidity and mortality. In critically ill surgical patients, obtaining tight glycemic control with intensive insulin therapy was shown to reduce morbidity and mortality and has increasingly become the standard of care. In addition to its well-known anti-hyperglycemic action and reduction in infections, insulin promotes muscle anabolism and regulates the systemic inflammatory response. Despite a demonstrated benefit of insulin administration on the maintenance of skeletal muscle mass, it is unknown if this effect translates to improved clinical outcomes in the thermally injured. Further, insulin therapy has the potential to cause hypoglycemia and requires frequent monitoring of blood glucose levels. A better understanding of the clinical benefit associated with tight glycemic control in the burned patient, as well as newer strategies to achieve and maintain that control, may provide improved methods to reduce the clinical morbidity and mortality in the thermally injured patient.",
keywords = "Burn ICU, GLP-1, Glycemic control, Insulin",
author = "Nikiforos Ballian and Atoosa Rabiee and Dana Andersen and Dariush Elahi and Gibson, {B. Robert}",
year = "2010",
month = "8",
doi = "10.1016/j.burns.2009.11.008",
language = "English (US)",
volume = "36",
pages = "599--605",
journal = "Burns",
issn = "0305-4179",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Glucose metabolism in burn patients

T2 - The role of insulin and other endocrine hormones

AU - Ballian, Nikiforos

AU - Rabiee, Atoosa

AU - Andersen, Dana

AU - Elahi, Dariush

AU - Gibson, B. Robert

PY - 2010/8

Y1 - 2010/8

N2 - Severe burn causes a catabolic response with profound effects on glucose and muscle protein metabolism. This response is characterized by hyperglycemia and loss of muscle mass, both of which have been associated with significantly increased morbidity and mortality. In critically ill surgical patients, obtaining tight glycemic control with intensive insulin therapy was shown to reduce morbidity and mortality and has increasingly become the standard of care. In addition to its well-known anti-hyperglycemic action and reduction in infections, insulin promotes muscle anabolism and regulates the systemic inflammatory response. Despite a demonstrated benefit of insulin administration on the maintenance of skeletal muscle mass, it is unknown if this effect translates to improved clinical outcomes in the thermally injured. Further, insulin therapy has the potential to cause hypoglycemia and requires frequent monitoring of blood glucose levels. A better understanding of the clinical benefit associated with tight glycemic control in the burned patient, as well as newer strategies to achieve and maintain that control, may provide improved methods to reduce the clinical morbidity and mortality in the thermally injured patient.

AB - Severe burn causes a catabolic response with profound effects on glucose and muscle protein metabolism. This response is characterized by hyperglycemia and loss of muscle mass, both of which have been associated with significantly increased morbidity and mortality. In critically ill surgical patients, obtaining tight glycemic control with intensive insulin therapy was shown to reduce morbidity and mortality and has increasingly become the standard of care. In addition to its well-known anti-hyperglycemic action and reduction in infections, insulin promotes muscle anabolism and regulates the systemic inflammatory response. Despite a demonstrated benefit of insulin administration on the maintenance of skeletal muscle mass, it is unknown if this effect translates to improved clinical outcomes in the thermally injured. Further, insulin therapy has the potential to cause hypoglycemia and requires frequent monitoring of blood glucose levels. A better understanding of the clinical benefit associated with tight glycemic control in the burned patient, as well as newer strategies to achieve and maintain that control, may provide improved methods to reduce the clinical morbidity and mortality in the thermally injured patient.

KW - Burn ICU

KW - GLP-1

KW - Glycemic control

KW - Insulin

UR - http://www.scopus.com/inward/record.url?scp=77953121747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953121747&partnerID=8YFLogxK

U2 - 10.1016/j.burns.2009.11.008

DO - 10.1016/j.burns.2009.11.008

M3 - Article

VL - 36

SP - 599

EP - 605

JO - Burns

JF - Burns

SN - 0305-4179

IS - 5

ER -